Strategic Programmes Office

The Chief Clinical Officer (CCO) is responsible for ensuring clinical leadership, including in medical, nursing, midwifery and health and social care professions, at the most senior level of the organisation and works closely with National Directors, other Clinical Leads and with senior leaders within Community Healthcare Organisations and Hospital Groups to improve patient and service user outcomes, safety and experience.

The Strategic Programmes Office (SPO) acts as an incubator for innovative new programmes of particular priority to the CCO and the organisation that require specialised assistance in their development, management and implementation.

The SPO brings together internal and external stakeholders, unites core competencies in the operational and clinical environments, engages directly with patients and service users, and drives major change initiatives that improve healthcare service delivery and span the HSE system-wide.

Ongoing programmes in 2023 include Modernised Clinical Pathways, the National Perioperative Patient Pathway Enhancement Programme (in collaboration with the RCSI and other partners), and the implementation of the National Strategy for Genetics and Genomics. Previously, the SPO was responsible for developing and implementing plans for the operational roll-out and use of novel COVID-19 therapeutics (programme now administered by the HSE Medicines Management Programme), the implementation of Public Health Reform in alignment with Sláintecare priorities, and the development of the National Strategy for Genetics and Genomics.

Programmes of Work


For more information about the work of the SPO, please email

For press queries, please contact the HSE National Press Office by email at or by phone at 01 921 3912